 | SCYNEXIS, Inc. | |||
| NGM : SCYX || Location: United States | ||||
$1.5-0.05 (-3.23%) |
0.09 M | 1.48 - 1.6 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 0.976 M |
| March 15, 2024 | 0.946 M |
| Feb. 29, 2024 | 1.044 M |
| Feb. 15, 2024 | 1.135 M |
| Jan. 31, 2024 | 1.146 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.20 | -0.39 | -91.18% |
| 09/30/2023 | -0.15 | -0.04 | 73.14% |
| 06/30/2023 | 1.58 | 2.46 | 55.79% |
| 03/31/2023 | -0.28 | -0.71 | -150.35% |
| 12/31/2022 | -0.45 | -0.37 | 17.56% |
SCYX Basic Data
| Sector | Healthcare | Industry | Drug Manufacturers - Specialty & Generic |
| Shares Outstanding | 37.754M | Shares Float | 37.274M |
| Short Float | 0.976M | Market Cap | 56.63M |
| Institution ownership | 48.40% | Insider ownership | 2.840% |
| Earnings Date | 05/09/2024 BMO | Cash Per Share | ? |
| Trailing EPS | 1.39 | Forward EPS | 0.01 |